+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Amiodarone and its putative metabolites fail to activate wild type hTAAR1



Amiodarone and its putative metabolites fail to activate wild type hTAAR1



Bioorganic and Medicinal Chemistry Letters 19(20): 5913-5914



The ability of amiodarone and its putative metabolites to activate unmodified human trace amine associated receptor 1 (hTAAR1) stably expressed in CHO cell lines was evaluated. Receptor activation was monitored by measuring the accumulation of cAMP, the putative hTAAR1 native second messenger, or calcium mobilization in cells where the receptor was coupled to the promiscuous Gq, Galpha16. Despite literature reports of activation of rodent TAAR1 by these agents, no response was seen in either cell line although robust activation was obtained with the endogenous ligand beta-phenethylamine. These results indicate that TAAR1 activation by amiodarone and its analogs is species specific.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051456935

Download citation: RISBibTeXText

PMID: 19740654

DOI: 10.1016/j.bmcl.2009.08.058


Related references

Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody. European Journal of Immunology 30(6): 1778-1784, 2000

Flavonoids activate wild-type p53. Oncogene 13(8): 1605-1614, 1996

Mutant and wild type p53 proteins activate topoisomerase I through their C terminus. Proceedings of the American Association for Cancer Research Annual Meeting 39: 28, 1998

Pharmacokinetics of amiodarone deethylamiodarone and other iodine containing amiodarone metabolites. European Journal of Clinical Pharmacology 29(4): 417-424, 1985

Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Molecular Cell 20(6): 963-969, 2005

A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53. FEBS Letters 517(1-3): 151-154, 24 April, 2002

Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation. Oncogene 13(11): 2315-2321, 1996

Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy. Seminars in Cancer Biology 20(1): 29-39, 2010

Weaver mouse cerebellar granule neurons fail to migrate on wild-type astroglial processes in vitro. Journal of Neuroscience 6(9): 2676-2683, 1986

Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway. American Journal of Physiology 276(2): C361, 1999

Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels. Journal of Experimental Medicine 187(9): 1487-1493, 1998

Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Elife 5:, 2016